Netherlands vs Solomon Islands: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Netherlands
88.0%
in 2024
Solomon Islands
88.0%
in 2024
Netherlands rank
75th
Solomon Islands rank
75th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Netherlands
- Solomon Islands
How they compare
Netherlands currently reports 88.0% against 88.0% in Solomon Islands, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Netherlands ahead.
Netherlands ranks 75th and Solomon Islands ranks 75th of 146 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.4% | 77.6% | 15.8% | Netherlands |
| 2020s | 90.4% | 87.4% | 3.0% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Netherlands or Solomon Islands?
- Netherlands, at 88.0% against 88.0% in Solomon Islands as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Netherlands and Solomon Islands?
- 0.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Solomon Islands?
- 10 years are reported by both, from 2015 to 2024.
- How do Netherlands and Solomon Islands rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Netherlands ranks 75th and Solomon Islands ranks 75th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.